Brind.
  1. Soligenix is developing products to treat rare diseases, addressing the lack of FDA-approved treatments for millions of Americans.

Ellen Kim is the Principal Investigator for Soligenix trials.

1 report, 0 independent Updated Jul 8
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Ellen Kim is the Principal Investigator for Soligenix trials.

Who's involved

What this event is mainly about
Soligenix (United States)Ellen Kim

Keep exploring

Part of

Soligenix is developing products to treat rare diseases, addressing the lack of FDA-approved treatments for millions of Americans.

Also in this story

All 3 developments

The entities involved

Coverage

Newest first; wire copies grouped
  • Unknown outlet